Blog

Zipcar and Zagster Launch Zipbike, the First National, Sponsored Bike-Share Program for Universities

September 20, 2016

Zipcar, the world’s leading car sharing network, and Zagster, the leader in campus bike sharing, today announced their partnership to launch Zipbike, the first national, sponsored bike-share program for universities. Zipbike aims to redefine campus mobility by accelerating access to, and adoption of, bike sharing at colleges and universities across the country. The combination of […]

Read More

Greenphire Executives To Participate In INC Research And CISCRP’s ‘Inspiring Hope’ Ideathon

September 20, 2016

Greenphire, the global leader in clinical payment solutions, recently announced that it will participate in INC Research and CISCRP’s “Inspiring Hope” Ideathon, a competition designed to promote greater awareness of the importance of clinical trial participation in advancing public health. The ideathon is being held in Boston on September 27 – 28. According to CISCRP, […]

Read More

RistCall replaces antiquated nurse call buttons with smart watch technology

September 20, 2016

Startup RistCall was founded August 2014 in Philadelphia, and recently completed Memphis Bioworks’ Zero to 510 medical device accelerator. Founder and CEO Srinath Vaddepally describes Ristcall as a game-changing technology, to disrupt the current nurse call button system found in hospitals and nursing homes. Ristcall has a software and a hardware component – – the […]

Read More

Essential Medical Inc. Announces Closing on $14.9M Series B Funding

September 20, 2016

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has completed a Series B financing of $14.9M. The round was led by Amzak Health along with original Series A investors including DSM Venturing, the venture investment arm of Royal DSM. Greg Walters, […]

Read More

Morphotek Announces Sponsored Research Agreement With Fox Chase Cancer Center To Study Immunosuppressive Effects Of Tumor Shed Antigens To Improve Future Patient Therapies

September 13, 2016

Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a Sponsored Research Agreement (SRA) with Fox Chase Cancer Center (FCCC) to expand its research efforts into the immunosuppressive effects elicited by tumor shed antigens on the efficacy of immune-based therapies. The collaboration will utilize primary human organoid cultures derived from various […]

Read More

Previous Next